Published on December 16, 2020
What Patients Should Know About CLL Testing
Navigating the landscape of chronic lymphocytic leukemia (CLL) testing can be overwhelming. What does your blood test result mean? Measurable Residual Disease (MRD) testing allows people to stop therapy, but how does that impact you? What trends can test results reveal about an individual’s overall health?
In this Answers Now segment, experts answer important questions about radiation, CT scans, MRIs, MRD, bloodwork, biopsies, and more. Patient Power co-founder and CLL survivor Andrew Schorr leads this discussion with Dr. Susan Leclair, PhD, Chancellor Professor Emerita, Department of Medical Laboratory Science at UMass Dartmouth, and Dr. Adam Kittai, MD, Hematologist at OSU Comprehensive Cancer Center.
This series is sponsored by AbbVie, Inc. and Genentech, Inc. These organizations have no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.
Recommended for You: